 |
인쇄하기
취소
|
Dongwha Pharm wins China patent for novel quinolone agent
Dongwha Pharm announced it has won China patent related to an optically active 7-pyrrolidine quinoline carboxylic acid derivative and its manufacturing method.
Dongwha officials said that the company invested two billion won for the development of such derivative. This novel antibiotic is under preclinical trials and has a broad spectrum of antimicrobial activity against gram-positive and g...
Dongwha officials said that the company invested two billion won for the development of such derivative. This novel antibiotic is under preclinical trials and has a broad spectrum of antimicrobial activity against gram-positive and g...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.